Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors.
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals.
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
Monitoring Natural SARS-CoV-2 Infection in Lions ( Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses